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ABSTRACT
PhosphoSitePlus (http://www.phosphosite.org) is
an open, comprehensive, manually curated and
interactive resource for studying experimentally
observed post-translational modifications, primarily
of human and mouse proteins. It encompasses
130000 non-redundant modification sites, primarily
phosphorylation, ubiquitinylation and acetylation.
The interface is designed for clarity and ease of
navigation. From the home page, users can launch
simple or complex searches and browse high-
throughput data sets by disease, tissue or cell
line. Searches can be restricted by specific treat-
ments, protein types, domains, cellular com-
ponents, disease, cell types, cell lines, tissue and
sequences or motifs. A few clicks of the mouse
will take users to substrate pages or protein
pages with sites, sequences, domain diagrams and
molecular visualization of side-chains known to be
modified; to site pages with information about how
the modified site relates to the functions of specific
proteins and cellular processes and to curated
information pages summarizing the details from
one record. PyMOL and Chimera scripts that
colorize reactive groups on residues that are
modified can be downloaded. Features designed
to facilitate proteomic analyses include downloads
of modification sites, kinase–substrate data sets,
sequence logo generators, a Cytoscape plugin
and BioPAX download to enable pathway visual-
ization of the kinase–substrate interactions in
PhosphoSitePlus.
INTRODUCTION
The cellular regulation of post-translational modiﬁcation
[PTMs; (1)] is complex and plays a fundamental role at all
levels of biological regulation. Protein phosphorylation,
partly because of its early links to metabolic regulation
(2) and cancer (3,4) has been the most widely studied
PTM. Throughout the 1990s, the number of physio-
logical substrates discovered grew signiﬁcantly; there was
a recognized need for an archive that systematically
collected protein kinase phosphorylation sites (5). Such
an archive, in order to be broadly useful to biologists
and biomedical researchers, needs to minimally include
not only the modiﬁed residue and surrounding sequence,
but also its regulation by treatments and ligands,
associated biological processes, upstream and downstream
interactions and location relative to protein domains and
other functional regions of the protein.
PhosphoSite (6), launched in 2003, was designed as a
resource that would comprehensively aggregate informa-
tion about the structure and regulatory interactions of
phosphorylation sites. At its launch it incorporated over
1200 journal articles identifying over 1200 non-redundant
sites on over 500 human and mouse proteins (Figure 1).
A total 12000 references have been incorporated since
then, with curated information including the regulation
by treatments and of protein interactions, roles in bio-
logical processes, disease relevance, kinase–substrate
interactions and relevant structural ﬁles and molecular
rendering tools. Initially, nearly all curated information
was derived from low-throughput (LTP) experimental
methods and so curation seemed eminently tractable.
This changed in the beginning of 2004 with
high-throughput (HTP) tandem mass spectrometry [MS;
(7)], when articles reporting many hundreds to thousands
of phosphorylation sites began appearing (8–10). This
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other modiﬁcation types including ubiquitination (11–13),
acetylation (14,15) and O-GlcNAcylation (16).
PhosphoSitePlus (PSP), reengineered from
PhosphoSite and launched in Feb 2008, is comprised of
129082 non-redundant sites on 14256 non-redundant
proteins (Table 1). Over 90% of these sites are from
human and mouse. Phosphorylation, acetylation and
ubiquitination are included, enabling the study of
cross-regulation between PTMs (16,17). Recent improve-
ments allow users to access content and tools not
previously accessible including: (i) queries for extracting
targeted sets of modiﬁcation sites, such as those responsive
to particular treatments, or found in particular types of
cancer or speciﬁc cellular compartments; (ii) downloads
of user-deﬁned interactive data sets and monthly
updated static data sets; (iii) the generation of sequence
logos to visualize speciﬁcity proﬁles; (iv) downloads
of Chimera (18) and (v) PyMol scripts that colorize
and label known modiﬁcation sites on molecular models;
and (vi) pathway visualizations of kinase-substrate
interactions.
Two resources in addition to PSP were launched in
2003–2004 that aggregated experimentally observed phos-
phorylation sites: HPRD (19) and phospho.ELM (20)
(Figure 1). A fourth, PHOSIDA (10), was launched in
the fall of 2006. HPRD aggregates information about
multiple types of PTMs, comprising 93710 instances, as
well as protein–protein interactions, subcellular localiza-
tion and tissue expression. Phospho.ELM is a database
of experimentally veriﬁed phosphorylation sites in eukary-
otic proteins. Its last release contains more than 42500
phosphorylation sites on 8718 proteins from different
species. PHOSIDA (21), ﬁrst described in November
2006 (10), archives only MS2 assignments, all of which
are derived from the same research group. It is comprised
of more than 80000 PTM sites from nine different species.
These include 24262 sites on 8283 human proteins and
25085 sites on 9234 mouse proteins. Modiﬁcation sites
in addition to phosphorylation, including O-glycosylation
and acetylation, have recently been included. SysPTM (22)
contains information curated from literature about nearly
50 PTM types, and is comprised of 117349 PTM sites
on 33421 proteins. CPLA (23) has aggregated 7151
experimentally identiﬁed acetylation sites in 3311 proteins.
DATA MANAGEMENT OF SEQUENCES,
STRUCTURES AND ASSOCIATED DATA
Protein sequences
Parent proteins are usually deﬁned as the longest of alter-
natively spliced isoforms. Protein sequences are imported
hierarchically: ﬁrst, from the reviewed, manually
annotated entries of UniProtKB/Swiss-Prot (24);
secondly, from NCBI/RefSeq (25) entries with accession
IDs beginning with NP; and thirdly, from unreviewed,
automatically annotated entries from UniProtKB/
TrEMBL or from RefSeq entries with accession IDs
beginning with XP. If no matches are found, then
Ensembl (26) entries are searched. When a new protein
sequence is imported, its human, mouse or rat orthologs
are also loaded. Isoform sequences other than that of
the parent protein are imported only when the only
evidence for the existence of the modiﬁcation site is
present in an isoform. Approximately 93% of sequences
in PSP are from UniPROT KB, 6% from NCBI and
<0.5% from Ensembl. The sequences and accession
numbers of parent proteins are synchronized with the
UniPROT KB every 6 months. All other sequences
are updated as needed during curation in order to
accommodate experimental results.
Additional protein data
Accession numbers from UniPROT KB, NCBI and
Ensembl (24–26), as well as gene symbols from HGNC
(27), are curated for all proteins when possible. Basic
protein descriptions include information parsed from
UniPROT KB (24), and may include additional informa-
tion from the literature. Descriptions are updated in
bulk occasionally. Gene Ontology (28) annotations are
parsed from NCBI (25). Editors assign protein types.
Figure 1. Informational content of PhosphoSite curated from the
literature from its launch in 2003 through 2011. Phosphorylation sites
(blue), proteins (red) and references (gray). The approximate dates that
descriptions of three other resources were published are indicated by
black arrows: HPRD (19), phospho.ELM (20) and PHOSIDA (21).
Inﬂection points indicate the publication of large MS data sets; a few
are marked with red arrowheads.
Table 1. Number of post-translationally modiﬁed proteins and
sites in PSP
Modiﬁcation type Proteins Sites
Serine phosphorylation 10704 65511
Threonine phosphorylation 7134 19609
Tyrosine phosphorylation 6460 15053
Ubiquitinylation 5139 18996
Acetylation 3287 7869
Sumoylation 356 622
O-Glycosylation 177 602
Di-methylation 167 378
Mono-methylation 153 303
Methylation 56 139
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A total of 22958 PDB (29) ﬁles corresponding to proteins
in PSP are stored locally for rendering molecular
structures opened by the default Astex Java viewer. PDB
(29) is queried monthly for new structures associated with
proteins in PSP. 4500 of the 14300 proteins in PSP, or
31%, have associated PDB ﬁles corresponding to some
segment of the protein’s sequence. 15307 sites, 12% of
all sites in PSP, are located within the resolved regions
of solved structures or within relatively unstructured
regions in which the modiﬁed residue is resolved,
e.g. Akt1 Lys14 in PDB_1H10: F..K*N..TFI..KER (30).
Protein and site groups
Individual modiﬁcation sites and proteins are organized
by orthologous (31) groups. Protein and site groups
include all members of the orthologous group. Unless
explicitly stated otherwise, the terms protein and site
shall apply to their respective groups throughout this
article. The associated numbers of proteins and sites are
thus non-redundant by deﬁnition, unless otherwise stated.
PSP ontology
Most curated information is parsed into the 27 controlled
vocabularies (CVs) that constitute the PSP ontology. 10 of
these CVs provide terms used in the search interfaces.
Database and application software
Data are stored in an Oracle 10 relational database with a
schema consisting of about 100 different tables. The cura-
torial interface is a custom-designed Java/Swing applica-
tion that enables curators to enter new data or modify
existing data if needed. The web interface is based on
Java/Struts/Hibernate running on a Tomcat 5 sever.
Links to antibody and siRNA products from cell
signaling technology
Proteins and modiﬁcation sites for which cell signaling
technology (CST) sells products are marked with links
to the appropriate product pages in the online catalog.
This arrangement for a comprehensive scientiﬁc resource
with commercial links was a part of research proposals
from CST that were funded by National Institutes of
Health Small Business Innovation Research grants.
CURATED MODIFICATION SITE CONTENT
Modiﬁcation sites
The total number of modiﬁcation sites is 129082 on
14256 proteins (Table 1). Seventy-eight percent are phos-
phorylation, 15% ubiquitination and 6% acetylation. The
numbers of discovered phospho-Tyr, ubiquitinyl-Lys and
acetyl-Lys have been greatly ampliﬁed by the availability
of appropriate afﬁnity reagents (9,13–15). For example,
pY constitutes only a few percent of total cellular
protein phosphorylation, but the systematic use of
anti-pY antibodies in MS2 protocols has increased its rep-
resentation in the known repertoire to 27%, 10-fold higher
than that expected based on its natural frequency. Note
that methylation here represents instances in which the
records did not distinguish between mono-, bi- or
tri-methylation.
Species
Although PTMs from 18 organisms are included in PSP,
99.7% are mammalian. The ﬁve organisms with the
highest numbers of PTMs are human (70338), mouse
(57862), rat (7665), cow (553) and chicken (366).
LTP content
Information from nearly 13000 papers and 600 different
journals characterizing modiﬁcation sites with LTP
methods has been curated into PSP. The top journals
and associated numbers of curated articles are: J Biol
Chem, 3665; Mol Cell Biol, 734; Oncogene, 546; Proc
Natl Acad Sci USA, 530; and EMBO J, 375. 10700 of
the sites in PSP have been observed with LTP methods.
7168 (67%) of these LTP sites are associated with only
1 record, 2745 (26%) with 2–5 records, 615 (6%) with
6–25 records and 173 (2%) with >25 records.
HTP content
Sites based on MS assignments can come either from
journal publications or from the CST research group
(9,32,33). Over 110 journal publications and 2258
curation sets from CST have been curated. Over 260000
(redundant) site assignments have been curated from
journal publications and over 65000 from CST curation
sets. A majority of sites in PSP have only been reported
using MS. Of 129668 sites, 116660 (90%) have been seen
only with MS. 72362 (62%) of these MS’ only sites are
associated with only 1 record, 30886 (26%) with
2–5 records, 11245 (10%) with 6–25 records, and 2116
(2%) with >25 records.
Data quality issues
If a recently curated paper includes site assignment scores,
only sites with scores of P0.95 or an Ascore 13 (34)
have been curated. Previously curated data sets that
contain numerical scores are being reanalyzed to exclude
sites that do not meet these standards to ﬁlter out as much
unreliable data as possible. Since most MS2 peptide and
site assignments are published en masse in unreviewed
Supplementary Tables and come from labs with different
experimental practices and levels of expertise, it is impos-
sible to implement a common acceptability standard on
MS2 data curated into PSP. [For a discussion of these
issues, see Ref. (35).] Users must use caution and good
judgment when evaluating site assignments based upon
MS2 methods alone.
USING PSP
This section outlines the navigational structure of PSP,
with a few examples that will help the user to effectively
navigate the site. Detailed navigational help is available
on the site itself. First, an online Flash tutorial
Nucleic Acids Research, 2012,Vol.40, Database issue D263(www.phosphosite.org/staticTrainingTutorial.do) under
the Using PhosphoSite tab provides instructions for use;
its index allows users to jump to a speciﬁc topic. Second,
links to help pages, indicated by question marks in
blue, are available in all search interfaces next to the red
SEARCH buttons.
Navigating PSP
The structure and navigation of PSP is outlined in
Figure 2 The site is organized around three types of
pages: search, results and informational. Searches are
initiated directly from the Homepage, advanced search
and browse pages. ‘Results’ pages are lists of items
matching the search string and are linked to Protein,
Site, or Reference Pages, depending upon the nature of
the query. Selection of an item from a ‘Results’ page
opens up the corresponding informational page. The
three informational pages (Protein, Modiﬁcation Site
and Curated Information) are all interlinked (Figure 2),
allowing for ease of navigation between levels. The
Homepage can be accessed from any page in the site by
clicking on the word Home in the upper left-hand corner.
Table 2 summarizes the modes for submitting searches
and the pages from which they are launched.
The Homepage is the hub of the site, the page from
which all functionalities and actions are initiated.
These include two types of simple searches and links to
three advanced search and three browse pages. The
Downloads, Links & Applications section on the lower
left part of the Homepage (Figure. 3) provides access to
multiple downloads and applications. The Downloadable
Data set section provides downloads of six different modi-
ﬁcation type data sets, an archive of all protein sequences
in PSP and the PSP Kinase-Substrate data set in three
formats: a tab-delimited text ﬁle, a Cytoscape Plugin
(36) and a ﬁle in BioPAX (37) format. The PSP Logo
Generator tool at this location accepts lists of aligned
sequences of identical length for sequence logo analysis.
Two algorithms are available for logo generation:
Frequency Change and PSP Production. Both differ
from the original algorithm (38) by graphing under- and
over-represented amino acids as negative and positive
values, respectively. The Frequency Change method is as
described (39). The PSP Production algorithm keeps the
sum of absolute values of the negative and positive
numbers equal to one, permitting a better view of amino
acids that are represented at frequencies closer to the
expected. In the example in Figure 3, ATM substrate se-
quences were separated into in vivo and in vitro groups and
analyzed with the PSP Logo Generator.
Homepage searches
Protein searches are initiated by submitting the name of
a protein in the Protein Name query ﬁeld. The results page
shows a list of all proteins whose primary or alternative
names matches the search string. Selecting a protein
opens up the corresponding Protein Page.
Substrate searches are initiated by entering the name of
a kinase in the Substrates Of query ﬁeld. The results page
will show a list of all kinases that match the query string.
Selecting a kinase opens up a downloadable list of experi-
mentally determined substrate sequences. The substrate
sequence preference of the kinase can be proﬁled by
clicking on Show Sequence Logo link at the top of the
page. This version of the sequence logo generator has
more options that the stand-alone version described
above: the modiﬁcation type, organism associated with
the kinase and modiﬁed amino acid(s) can all be
selected. The data set used to generate the logo includes
only one representative for each site group, eliminated
bias due to over-representation of multiple instances
of orthologous sites.
‘Homepage informational content’ includes the What’s
New section that describes new features that are not in the
tutorial and site statistics that are updated daily. Four tabs
in the upper right-hand corner open up informational
pages describing the function, content and contact
information for PSP.
Advanced searches
There are three search interfaces: (i) Protein, Sequence or
Reference Search; (ii) Site Search and (iii) Comparative
Table 2. Four search pages and types of queries launched from them:
T, text; L, text list, C, controlled vocabulary
Query term Homepage Advanced search pages
Protein,
sequence,
site search
comparative
Reference
search
Site
search
Kinase T
Protein T T,L
Accession ID T,L
PubMed ID T,L
Author T
Sequence or motif T,L T
Molecular weight T T
Protein type C C C
Cellular component C C C
Domain C C C
Treatment C C
Cell line C C
Cell type C C
Tissue C C
Disease C C
Biological process C
Molecular function C
Figure 2. Overview of the navigational ﬂow and content of PSP.
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Advanced Search Pages (Table 2). Users can search by
one or multiple parameters connected by the AND
operator.
Seven search ﬁelds accept free text. Ten ﬁelds, marked
with a blue SELECT button on the search interfaces, only
accept pre-curated terms that need to be selected from
the CVs.
Searching from pre-curated terms in the advanced search
pages. Successful searches using terms from a CV
requires ﬁve steps: (i) click on the blue SELECT button
to open the Selection Window. Wait for the list of terms to
appear in the middle window; (ii) begin typing letters in
the search ﬁeld at the top of the page, reducing the avail-
able terms shown in the search window; (iii) when the
intended search term is found, highlight it and click the
ADD button. The selected term will appear in the query
frame at the bottom of the page; (iv) when all desired
search terms have been selected and in the lower frame,
click the SUBMIT button at the bottom of the Selection
Window. This will populate the search ﬁeld in the Search
Page with the selected terms; and (v) initiate the search
(ﬁnally) by clicking the red SEARCH button at the
bottom of the frame.
Protein, sequence or reference searches. Protein Searches
retrieve lists of proteins based on seven query types
(Table 2). The sequence/motif search in this frame is
case-insensitive, unlike that in the following Sequence
Search. It retrieves the names of all proteins in PSP that
contain the speciﬁed sequence.
‘Sequence searches’ retrieve lists of proteins and
sequences containing speciﬁed sequences, degenerate
motifs and domains. The powerful and versatile search
syntax, patterned after the Swiss Institute of
Bioinformatics’ ScanProsite tool (40), has been modiﬁed
in this interface to interpret lower case letters as modiﬁed
residues when the check box is turned on. For example,
a search for [VIL]SXXSR returns 2136 hits without the
box checked. With the box checked, a search for
[VIL]sXXSR returns 60 hits and [VIL]sXXsR returns
26 hits. A unique search from the Sequence Search
section allows users to submit a list of peptides and organ-
isms to search for known PTMs on the peptide. When
a match is found, the sequence is added to the output
with the known sites marked.
‘Reference searches’ retrieve lists of literature references
speciﬁed by authors, proteins or PubMedIDs. Author
searches only accept one last name. Reference Search
Results link to the PubMed citation and to Curated
Information pages.
Site Searches and comparative site searches. Site Searches
retrieve lists of modiﬁed sites matching the selected
criteria. Comparative Site Searches retrieve sites that
possess speciﬁed attributes and exclude others. Both can
Figure 3. The Downloads, Links and Applications section provides (1) multiple modiﬁcation site data sets from PhosphoSitePlus, the complete
archive of current reference proteins (Phosphosite_seq), and the extensive Kinase–Substrate data set in three formats: the Kinase_Substrate_Data set
is a tab-delimited txt ﬁle, a Cytoscape Plugin (phosphositeClient_jar), and BioPAX format (37); (2) a logo generator with which users can analyze
uploaded data sets; (3) ATM substrate sequences extracted from the kinase-substrate data set were segregated into in vitro and in vivo reactions and
(4) analyzed using the PSP Logo Generator and (5) a subset of the data extracted from PSP and visualized using Cytoscape (36).
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restricted by an additional four parameters (Table 2).
‘Browse interfaces’ retrieve lists of sites associated with
diseases, cell lines or tissues. Results are returned in a table
with a different column for each associated record.
Selecting one of the three types opens a listing of all
instances of each type. These include 48 disease listings,
244 cell lines and 24 tissues. Note that for diseases, both
parent and children terms are listed, resulting in listings
for leukemia as well as for T-cell leukemia, chronic
myelogenous leukemia, etc. Clicking on one of the
diseases, cell lines or tissues opens a list of all associated
records. Upon selecting and submitting the desired
records, a table will be generated and downloaded to
your desktop containing a separate column for each
record and if there are multiple samples in each record,
separate columns for them.
Informational pages
Protein Pages aggregate a variety of structural and func-
tional information about the protein, as well as organizing
all modiﬁcation sites. Site Pages present detailed informa-
tion about that site, its biological characteristics (including
regulation, effects, disease and references). Curated
Information Pages, the most granular in PSP, outline
the experimental details curated for all sites reported in
the article. Only Protein Pages, the most widely visited
informational page, will be considered in greater detail
below.
‘Protein Pages’ are divided into four sections. The
topmost is the ‘Overview Section’, an example of which
is shown in Figure 4 for the protein YAP1. It provides
key information about the protein including a brief
description, GO terms and links related to the speciﬁc
Figure 4. Protein Page overview section for YAP1. (lower left) The linked Hippo Pathway from CST, with links to PSP proteins, can be opened
and downloaded from this page. (lower right) Selected PDF ﬁles, in this case 3KYS (46), can be opened in the Viewer window with the
OpenAstexViewer (41).
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link is provided to its online version (Figure 4 lower
left). Clicking on the Open Viewer button will open
the chosen PDB ﬁle in the Viewer window with the
OpenAstexViewer (41)( Figure 4, lower right). The
rendered structure includes labels on the modiﬁable
amino acids that have been identiﬁed in PSP. The
reactive side-chain groups (hydroxyl and e-amino) are
color coded by modiﬁcation type. Scripts for rendering
the structure with colored and labeled modiﬁable side
chain groups in PyMOL and Chimera (18) can be down-
loaded from the upper right-hand corner of the Viewer
window. The second section of the Protein Page (data
not shown) lists modiﬁed residues and brieﬂy summarizes
the consequences of the modiﬁcation on the protein’s
function or biological processes, with hyperlinks to the
relevant Site Pages where more detail is available. The
lower two sections of the YAP1 protein page are shown
in Figure 5. The ‘Modiﬁcation Sites and Domains’ section
(Figure 5A) of the Protein Page provides a zoomable
linear representation of the protein sequence, modiﬁcation
sites and Pfam-A domains. Purported transmembrane
segments, extracted from UniPROT KB, are labeled
with TM. Lower case letters represent modiﬁed residues
in all sequences. The ‘Modiﬁcation sites in parent protein,
ortholog and isoforms’ section (Figure. 5B) provides
a table of modiﬁcation sites and ﬂanking sequences.
The two left most columns outlined in red show the
total number of times the site was characterized using
low-throughput site-speciﬁc methods (SS) or mass spec-
trometry (MS) across all species and isoforms; these
numbers are linked to a Site Group page summarizing
the references.
RESULTS AND DISCUSSION
Overlap of MS and LTP phosphorylation sites
The overlap of LTP with MS sites in PSP is 48%
(5229 out of 10727 LTP sites), considerably higher than
the 17% (846 out of 5095 LTP sites) previously
reported (20). The 2.6-fold higher overlap rate may
reﬂect the larger sample size in the present article, which
is based on 100249 phosphorylation sites compared
to 38259 (20).
Location of various modiﬁcation types within protein
structures
It has been observed that protein Ser/Thr phosphorylation
occurs predominantly within intrinsically disordered
protein regions (42,43), which are mainly outside of struc-
tural domains. In order to determine if other modiﬁcation
types are similarly situated, the location of pS/T modiﬁ-
cations and three other modiﬁcation types were scored
Figure 5. Protein Page sections 3 and 4 for YAP1. (A) The Modiﬁcation Sites and Domains section. (B) Modiﬁcation Sites in Parent Protein,
Orthologs, and Isoforms section. The two left most columns outlined in red show the total number of references using SS or MS to characterize
the site group.
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The results (Figure 6) show that 77% of phospho-Ser/
Thr (pS/T) sites occur outside structured domains, a
result consistent with previous observations (42,43). Two
of three other modiﬁcation types do not follow this
pattern. A 23% of the pS/T sites occur within domains,
while 45% of the phospho-Tyr sites and 56% of the
acetyl-Lys (acK) sites fall within domains, a 2.0- and
2.4-fold increase, respectively. The distribution of
ubiquitinyl-Lys (ubK) is similar to that of pS/T. The
relative increase of the pY content within domains
may reﬂect the conservation of these sites, many of
which are regulatory, compared to pY sites located
between domains, which may reﬂect the disproportionate
loss of tyrosines that has occurred during metazoan
evolution (45).
Using structural information to identify potentially
important regulatory PTMs
The molecular visualization capabilities of PSP, recently
improved with the addition of downloadable Chimera and
PyMOL scripts, are designed to enable researchers
to quickly identify modiﬁcation sites that lie within
domains and to visualize the topology of the modiﬁed
amino acid. The exact position of the modiﬁed site may
change from that of the unmodiﬁed site in the structure
but the ﬁrst-order approximation afforded by this view
allows for rapid identiﬁcation of sites that may be func-
tionally signiﬁcant. The following examples using the
small G protein RAN show how these tools might be
useful when evaluating previously unreported sites that
are found in PSP. The table of modiﬁcation sites at the
bottom of the RAN Protein Page (Figure 7A) shows two
regions in the Ras domain that have elevated levels of
PTMs: Lys-71 is acetylated and ubiquitinylated and
Tyr-147 and -155 are phosphorylated The RAN PDB
ﬁle 3CH5 was opened from the drop down menu in the
molecular viewer section of the h. Figure 7B shows
Tyr-147 and -155 in the default viewer. The ChimeraX
script was downloaded from the upper right-hand side
of the default viewer window and opened in Chimera
(Figure 7C). Examining the same section as shown in
Figure 7B, Tyr-147 and -155 appear to be interposed in
a hydrophobic region between two a-helices, suggesting
that the phosphorylation of these residues has the poten-
tial to open this region up and affect the function of RAN.
Figure 7D shows that the e-amino group of Lys-71 (green)
is very close (1.29A ˚ ) from O2B of the GDP molecule,
suggesting that modiﬁcation of this lysine may affect
the binding of RAN to GDP (and GTP). Both of these
possibilities present testable hypotheses, and show that
PSP might be used to quickly identify potentially interest-
ing functional roles of PTMs that lie within regions of
a protein for which there are solved structures. This sort
of analysis is limited to those 15307 site groups that are
located within the resolved regions of solved structures.
CONCLUSION
As seen in Figure 1, we are in the middle of a period of
rapid expansion of information about post-translationally
modiﬁed sites discovered using both LTP and HTP
technologies. Trying to keep up and to ﬁgure out how it
all ﬁts together is a fantastic challenge. LTP literature
Figure 7. The topology of modiﬁed residues from PSP on the small G
protein RAN visualized with the PDB ﬁle for 3CH4. (A) The table of
modiﬁcation sites on the Ran (human) Protein Page. (B) PDB 3CH5
was opened in the Astex viewer. Tyr-147 and -155 are marked. (C) The
PSP ChimeraX script was downloaded and opened in Chimera. Tyr-147
and -155 are marked, and the tyrosyl hydroxyls that can be
phosphorylated are colored red. (D) Chimera model of 3CH4 in
space-ﬁlling mode. The acetylated e-amino group of Lys-71 is colored
green.
Figure 6. The locations of four protein posttranslational modiﬁcations
relative to Pfam-A domains. The locations of 4 modiﬁcation types were
scored as either inside or outside of Pfam-A domains. pS/T, phospho-
Ser/-Thr; pY, phospho-Tyr; acK, acetyl-Lys; ubK, ubiquitinyl-Lys.
D268 Nucleic AcidsResearch, 2012, Vol.40,Database issueis regularly scanned for reports of new sites and for new
information about established sites that contribute to our
understanding of the site. The natural language processing
software I2E from Linguamatics is helping us identify
and preprocess the growing volume of LTP literature.
Curation, however, is still done manually in-house.
Curation of HTP literature possess the challenges of
throughput and quality. We periodically upgrade the pro-
cessing software to improve throughput and reevaluate the
quality standards of sites that are already in PSP and those
yet to be entered. PSP will continue to aggregate both LTP
and HTP information in order to remain a comprehensive
resource about PTMs for biomedical researchers.
Hopefully PSP will prove useful to researchers trying
to ﬁgure out how it all ﬁts together.
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